Assessing Cognitive and Psychomotor Performance Under Long-Term Treatment with Transdermal Buprenorphine in Chronic Noncancer Pain Patients
Authors:
- Hans J. GerbershagenHGHans J. Gerbershagen
- Werner WagnerWWWerner Wagner
- Frank PetzkeFPFrank Petzke
- Lukas RadbruchLRLukas Radbruch
- Rainer SabatowskiRSRainer Sabatowski
- 1 November 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 105 (5) , 1442-1448
Abstract
The therapeutic use of opioids has been associated with altered cognition and impaired psychomotor function. Several studies have demonstrated the impact of opioid therapy on psychomotor performance and cognition, but there are no data about the effect of long-term treatment with transdermal buprenorphine on driving ability. Thirty patients suffering from chronic noncancer pain, who had been treated with stable doses of transdermal buprenorphine, included in a prospective trial and compared with 90 healthy volunteers (matched pairs). A computerized test battery, developed to assess the driving ability of traffic delinquents in Germany, was used. Attention reaction, visual orientation, motor coordination, and vigilance were evaluated. The data from 14 variables were assessed, and for each test, a relevant score was defined. As the primary end-point, the sum score of the three relevant scores was determined. A weaker statistical means to assess the patient's performance is to compare the test results to an age-independent control group. Individuals performing worse than the 16th percentile of this control group are considered to be unable to drive according to German law. According to tests that predict driving ability, patients receiving transdermal buprenorphine were shown to be noninferior to the control group. Driving ability, as defined as a result above the 16th percentile, did not differ significantly between the patients and the control group. Long-term use of transdermal buprenorphine for chronic noncancer pain does not impair driving ability, but because of the individual variability of test results, an individual assessment is recommended.Keywords
This publication has 33 references indexed in Scilit:
- Stable long-term opioid medication per se does not always cause loss of driving ability: the doctor and patient must consider additional risk factors for unsafe drivingActa Anaesthesiologica Scandinavica, 2006
- Assessing cognition and psychomotor function under long‐term treatment with controlled release oxycodone in non‐cancer pain patientsActa Anaesthesiologica Scandinavica, 2006
- The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative carePain, 2005
- Buprenorphine: Considerations for Pain ManagementJournal of Pain and Symptom Management, 2005
- Transdermal BuprenorphineDrugs, 2003
- Opioid Therapy for Chronic Noncancer Back PainSpine, 1998
- Alertness, cognition and morphine in patients with advanced cancerCancer Treatment Reviews, 1996
- Using Alcohol as a Standard to Assess the Degree of Impairment Induced by Sedative and Analgesic Drugs Used in Ambulatory SurgeryAnesthesiology, 1995
- Antidepressiva und VerkehrssicherheitFortschritte der Neurologie · Psychiatrie, 1994
- Long-term oral opioid therapy in patients with chronic nonmalignant painJournal of Pain and Symptom Management, 1992